mebendazole has been researched along with Sepsis in 1 studies
Mebendazole: A benzimidazole that acts by interfering with CARBOHYDRATE METABOLISM and inhibiting polymerization of MICROTUBULES.
mebendazole : A carbamate ester that is methyl 1H-benzimidazol-2-ylcarbamate substituted by a benzoyl group at position 5.
Sepsis: Systemic inflammatory response syndrome with a proven or suspected infectious etiology. When sepsis is associated with organ dysfunction distant from the site of infection, it is called severe sepsis. When sepsis is accompanied by HYPOTENSION despite adequate fluid infusion, it is called SEPTIC SHOCK.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mahomed, AA | 1 |
| MacKenzie, RN | 1 |
| Carson, LS | 1 |
| Jibril, JA | 1 |
1 other study available for mebendazole and Sepsis
| Article | Year |
|---|---|
Enterobius vermicularis and perianal sepsis in children.
Topics: Antinematodal Agents; Anus Diseases; Child; Enterobiasis; Humans; Mebendazole; Sepsis | 2003 |